2013 MCMi Regulatory Science Symposium Program

First Page		Document Content
Pharmacology United States Department of Health and Human Services Clinical pharmacology United States Public Health Service Influenza vaccine Influenza Center for Biologics Evaluation and Research Biomedical Advanced Research and Development Authority MedImmune Health Medicine Food and Drug Administration		2013 MCMi Regulatory Science Symposium Program Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 560,24 KB Share Document on Facebook

	One MedImmune Way Gaithersburg, MDTO: Immunization Provider or Awardee DocID: 1pDIX - View Document
	MedImmune and Tanabe Research Laboratories / Mitsubishi Tanabe Pharma Enter into Strategic Collaboration and Licensing Agreement for the Development of Pyrrolobenzodiazepine (PBD)-Based Antibody Drug Conjugates to Treat DocID: 1lU0o - View Document
	Green Registry 2015 Leadership Award Winner AstraZeneca/MedImmune n About AstraZeneca/MedImmune DocID: 1l9EK - View Document
	July 22, 2014 Advaxis and MedImmune Partner on Immuno-Oncology Combination Clinical Trial PRINCETON, N.J., July 22, 2014 (GLOBE NEWSWIRE) --Advaxis, Inc. DocID: 1jdz3 - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SYNAGIS safely and effectively. See full prescribing information for SYNAGIS. SYNAGIS® (palivizumab) injection, for DocID: 1gqM3 - View Document